Lv1
20 积分 2022-01-12 加入
Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial
2天前
已完结
Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab
2天前
已完结
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
15天前
已完结
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
15天前
已完结
Emerging Options and Future Strategies in Immunotherapy for Advanced Lung Squamous Cell Carcinoma
16天前
已完结
[Chinese expert consensus on clinical testing standards of PD-L1 expression for non-small cell lung cancer (2023 version)]
1个月前
已完结
Combination of Radiotherapy and Immunotherapy in Advanced Non–Small Cell Lung Cancer
1个月前
已完结
Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma
2个月前
已完结
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking
2个月前
已完结
Activity and safety of atezolizumab plus carboplatin and paclitaxel in patients with advanced or recurrent thymic carcinoma (MARBLE): a multicentre, single-arm, phase 2 trial
2个月前
已完结
皖公网安备34019202002308
